Preclinical In-Vivo Imaging Market

The global preclinical in vivo imaging solutions market is foreseen to grow at 5.9%, from USD 580.4 Million in 2021 to USD 918.1 Million in 2029. Technological advancements in the field of molecular imaging, increasing market demand for noninvasive small-animal imaging techniques, growing number of public-private initiatives and funding to support preclinical researches are the factors driving the growth of the global preclinical in vivo imaging solutions market. However, strict regulations governing preclinical research, significant installation and operational costs associated with preclinical imaging modalities is anticipated to restrain the market growth for the estimated period.

Market Definition

What is Preclinical In Vivo Imaging Solutions?

Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes.

Research Scope

The report provides market value for base year 2021 and a yearly forecast from 2022 to 2029 in terms of revenue (USD Million). Market for each segment is present on North America, Europe, Asia Pacific, Latin America and Middle East & Africa as well as regional basis for the above-mentioned forecast period.

Key industry dynamics, regulatory scenario, major material dynamics and Preclinical In Vivo Imaging Solutions future markets are analyzed to understand their impact on demand for the forecast period. Growth rates have been estimated using correlation, regression and time-series analysis.

Market Overview

Preclinical In Vivo Imaging Solutions Market report also provide a thorough understanding of the cutting-edge competitive analysis of the emerging market trends along with the drivers, restraints, challenges, and opportunities in the Preclinical In Vivo Imaging Solutions Market to offer worthwhile insights and current scenario for making right decision. The report covers the prominent players in the market with detailed SWOT analysis, financial overview, and key developments of the products/services from the past three years. Moreover, the report also offers a 360º outlook of the market through the competitive landscape of the global industry player and helps the companies to garner Preclinical In Vivo Imaging Solutions Market revenue by understanding the strategic growth approaches.

Preclinical In Vivo Imaging Solutions Market study by “Zettabyte Analytics” provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years.

Market Segmentation

For the purpose of this report, the global Preclinical In Vivo Imaging Solutions Market is segmented on the basis of Modality Type, Reagent and region:

Modality Type Outlook:

On the basis of Modality Type, the market is segmented into Micro-CT, Micro-MRI, Micro-Ultrasound, Nuclear Imaging Systems, Optical Imaging Systems, Other Imaging Systems. Further, Nuclear Imaging Systems is segmented into Micro-PET Systems, Micro-Spect Systems, Trimodality (Spect/PET/CT) Systems. Further, Optical Imaging Systems is segmented into Bioluminescence/Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems, (Optical + X-Ray)/(Optical + CT) Systems.

Figure 1 - Preclinical In Vivo Imaging Solutions Market, By Modality Type (Market Size And Forecast By Value - USD Million, 2021 & 2029)